Genetic analysis results showed that 36 out of 354 tested breast and ovarian cancer patients were BRCA1/2 mutation carriers (31 breast cancer cases and 5 ovarian cancer patients), including 21 patients with BRCA1 mutation and 15 patients carrying BRCA2 mutation. Here, BRCA2 is linked to breast carcinoma.